Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
A key feature of effective investing lies in securing superior returns without a proportionate increase in risk. Benjamin Graham was a pioneer of the margin of safety principle, which serves as a foundation for our technology. Although risk can never be fully eradicated, our focus is on identifying exceptional companies that are undervalued, thereby reducing the inherent risks associated with stock investments. Another strategy involves quantitative investing, where one invests in a collection of stocks—often around 40—that share specific winning characteristics. These characteristics are based on over 200 quantitative and qualitative metrics calculated for each stock. This evaluation results in the AI-score, which ranges from -100 to 100 and reflects the stock's investment appeal. Joe is dedicated to helping you achieve better returns on your investment. He finds satisfaction in investing in a remarkable business that demonstrates strong growth potential and possesses an excellent business model, all while being acquired at a price significantly below its true worth. Ultimately, this strategic approach allows for both growth and risk management in the investment landscape.
Description
Intrinsic's Clinical Trial Management System (Intrinsic’s CTMS®) is thoughtfully crafted with the user experience in focus, aiming to reduce data input and enhance proactive oversight of studies. As a cloud-based platform featuring an efficient interface, it allows for comprehensive study management across various levels and employs a task-oriented approach, marking a significant advancement in trial management solutions. Notably, Intrinsic® is the pioneering CTMS that offers seamless integration with all Microsoft applications, including Outlook, Excel, SharePoint, and Power BI. The introduction of Dynamic Worksheets enables users to effortlessly import large sets of data and updates from CROs via their clinical trial management software, eliminating the need for complex system integrations, while also allowing for the generation of 'live' exports for on-the-fly analysis and reporting. Additionally, Intrinsic CTMS® harnesses the capabilities of Power BI, a cloud-based reporting tool, empowering users to create reports from other clinical systems, such as EDC and IRT, without the burden of developing expensive data warehouses. This innovative approach not only simplifies data management but also enhances the overall efficiency of clinical trial processes.
API Access
Has API
API Access
Has API
Integrations
No details available.
Integrations
No details available.
Pricing Details
$49 per month
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
Formula Stocks
Country
Denmark
Website
formulastocks.com
Vendor Details
Company Name
Intrinsic Clinical Systems
Founded
2013
Country
United States
Website
www.intrinsiccs.com
Product Features
Investment Management
Accounting Management
Benchmarking
Bonds / Stocks
Client Management
Commodities
Compliance Reporting
Data Import / Export
For Investment Advisors
For Investors & Traders
Fund Management
Modeling & Simulation
Payroll & Commissions
Performance Metrics
Portfolio Management
Risk Management
Product Features
Clinical Trial Management
21 CFR Part 11 Compliance
Document Management
Electronic Data Capture
Enrollment Management
HIPAA Compliant
Monitoring
Patient Database
Recruiting Management
Scheduling
Study Planning